Galit Weinstein1, Alexa S Beiser, Charles Decarli, Rhoda Au, Philip A Wolf, Sudha Seshadri. 1. From the Department of Neurology, Boston University School of Medicine, Boston, MA (G.W., A.S.B., R.A., P.A.W., S.S.); The Framingham Heart Study, Boston, MA (G.W., A.S.B., R.A., P.A.W., S.S.); Department of Biostatistics, Boston University School of Public Health, Boston, MA (A.S.B.); and the Department of Neurology, University of California at Davis, Sacramento, CA (C.D.).
Abstract
BACKGROUND AND PURPOSE: Exposure to vascular risk factors has a gradual deleterious effect on brain MRI and cognitive measures. We explored whether a pattern of these measures exists that predicts stroke and Alzheimer disease (AD) risk. METHODS: A cognitive battery was administered to 1679 dementia and stroke-free Framingham offspring (age, >55 years; mean, 65.7±7.0) between 1999 and 2004; participants were also free of other neurological conditions that could affect cognition and >90% also had brain MRI examination. We related cognitive and MRI measures to risks of incident stroke and AD ≤10 years of follow-up. As a secondary analysis, we explored these associations in The Framingham Heart Study original cohort (mean age, 67.5±7.3 and 84.8±3.3 years at the cognitive assessment and MRI examination, respectively). RESULTS: A total of 55 Offspring participants sustained strokes and 31 developed AD. Offspring who scored <1.5 SD below predicted mean scores, for age and education, on an executive function test, had a higher risk of future stroke (hazard ratio [HR], 2.27; 95% confidence interval [CI], 1.06-4.85) and AD (HR, 3.60; 95% CI, 1.52-8.52); additional cognitive tests also predicted AD. Participants with low (<20 percentile) total brain volume and high (>20 percentile) white matter hyperintensity volume had a higher risk of stroke (HR, 1.97; 95% CI, 1.03-3.77 and HR, 2.74; 95% CI, 1.51-5.00, respectively) but not AD. Hippocampal volume at the bottom quintile predicted AD in the offspring and original cohorts (HR, 4.41; 95% CI, 2.00-9.72 and HR, 2.37; 95% CI, 1.12-5.00, respectively). A stepwise increase in stroke risk was apparent with increasing numbers of these cognitive and imaging markers. CONCLUSIONS: Specific patterns of cognitive and brain structural measures observed even in early aging predict stroke risk and may serve as biomarkers for risk prediction.
BACKGROUND AND PURPOSE: Exposure to vascular risk factors has a gradual deleterious effect on brain MRI and cognitive measures. We explored whether a pattern of these measures exists that predicts stroke and Alzheimer disease (AD) risk. METHODS: A cognitive battery was administered to 1679 dementia and stroke-free Framingham offspring (age, >55 years; mean, 65.7±7.0) between 1999 and 2004; participants were also free of other neurological conditions that could affect cognition and >90% also had brain MRI examination. We related cognitive and MRI measures to risks of incident stroke and AD ≤10 years of follow-up. As a secondary analysis, we explored these associations in The Framingham Heart Study original cohort (mean age, 67.5±7.3 and 84.8±3.3 years at the cognitive assessment and MRI examination, respectively). RESULTS: A total of 55 Offspring participants sustained strokes and 31 developed AD. Offspring who scored <1.5 SD below predicted mean scores, for age and education, on an executive function test, had a higher risk of future stroke (hazard ratio [HR], 2.27; 95% confidence interval [CI], 1.06-4.85) and AD (HR, 3.60; 95% CI, 1.52-8.52); additional cognitive tests also predicted AD. Participants with low (<20 percentile) total brain volume and high (>20 percentile) white matter hyperintensity volume had a higher risk of stroke (HR, 1.97; 95% CI, 1.03-3.77 and HR, 2.74; 95% CI, 1.51-5.00, respectively) but not AD. Hippocampal volume at the bottom quintile predicted AD in the offspring and original cohorts (HR, 4.41; 95% CI, 2.00-9.72 and HR, 2.37; 95% CI, 1.12-5.00, respectively). A stepwise increase in stroke risk was apparent with increasing numbers of these cognitive and imaging markers. CONCLUSIONS: Specific patterns of cognitive and brain structural measures observed even in early aging predict stroke risk and may serve as biomarkers for risk prediction.
Entities:
Keywords:
Alzheimer disease; cognition; magnetic resonance imaging; stroke
Authors: Cleusa P Ferri; Martin Prince; Carol Brayne; Henry Brodaty; Laura Fratiglioni; Mary Ganguli; Kathleen Hall; Kazuo Hasegawa; Hugh Hendrie; Yueqin Huang; Anthony Jorm; Colin Mathers; Paulo R Menezes; Elizabeth Rimmer; Marcia Scazufca Journal: Lancet Date: 2005-12-17 Impact factor: 79.321
Authors: Gloria C Chiang; Philip S Insel; Duygu Tosun; Norbert Schuff; Diana Truran-Sacrey; Sky Raptentsetsang; Clifford R Jack; Michael W Weiner Journal: Radiology Date: 2011-04-05 Impact factor: 11.105
Authors: Michael J Pencina; Ralph B D'Agostino; Karol M Pencina; A Cecile J W Janssens; Philip Greenland Journal: Am J Epidemiol Date: 2012-08-08 Impact factor: 4.897
Authors: Cristina S Ivan; Sudha Seshadri; Alexa Beiser; Rhoda Au; Carlos S Kase; Margaret Kelly-Hayes; Philip A Wolf Journal: Stroke Date: 2004-04-29 Impact factor: 7.914
Authors: Mariëlle M F Poels; Ewout W Steyerberg; Renske G Wieberdink; Albert Hofman; Peter J Koudstaal; M Arfan Ikram; Monique M B Breteler Journal: J Neurol Neurosurg Psychiatry Date: 2012-08-23 Impact factor: 10.154
Authors: Rhoda Au; Sudha Seshadri; Philip A Wolf; Merrill Elias; Penelope Elias; Lisa Sullivan; Alexa Beiser; Ralph B D'Agostino Journal: Exp Aging Res Date: 2004 Oct-Dec Impact factor: 1.645
Authors: Tom Jeerakathil; Philip A Wolf; Alexa Beiser; Joseph Massaro; Sudha Seshadri; Ralph B D'Agostino; Charles DeCarli Journal: Stroke Date: 2004-06-24 Impact factor: 7.914
Authors: Elissa H Wilker; Sarah R Preis; Alexa S Beiser; Philip A Wolf; Rhoda Au; Itai Kloog; Wenyuan Li; Joel Schwartz; Petros Koutrakis; Charles DeCarli; Sudha Seshadri; Murray A Mittleman Journal: Stroke Date: 2015-05 Impact factor: 7.914
Authors: Chuanhui Dong; Nooshin Nabizadeh; Michelle Caunca; Ying Kuen Cheung; Tatjana Rundek; Mitchell S V Elkind; Charles DeCarli; Ralph L Sacco; Yaakov Stern; Clinton B Wright Journal: Neurology Date: 2015-07-08 Impact factor: 9.910
Authors: Ramit Ravona-Springer; Salo Haratz; David Tanne; James Schmeidler; Shai Efrati; Clive Rosendorff; Michal Schnaider Beeri; Jeremy M Silverman Journal: J Alzheimers Dis Date: 2015 Impact factor: 4.472
Authors: Kumar B Rajan; Julie A Schneider; Neelum T Aggarwal; Robert S Wilson; Susan A Everson-Rose; Denis A Evans Journal: J Stroke Cerebrovasc Dis Date: 2015-09-19 Impact factor: 2.136
Authors: Clinton B Wright; Chuanhui Dong; Michelle R Caunca; Janet DeRosa; Ying Kuen Cheng; Tatjana Rundek; Mitchell S V Elkind; Charles DeCarli; Ralph L Sacco Journal: Alzheimer Dis Assoc Disord Date: 2017 Jan-Mar Impact factor: 2.703
Authors: Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Mary Sano; Rachel Preiss; Keren Koifman; Hadas Hoffman; Jeremy M Silverman; Michal Schnaider Beeri Journal: Eur Neuropsychopharmacol Date: 2014-05-14 Impact factor: 4.600
Authors: Galit Weinstein; Shira Zelber-Sagi; Sarah R Preis; Alexa S Beiser; Charles DeCarli; Elizabeth K Speliotes; Claudia L Satizabal; Ramachandran S Vasan; Sudha Seshadri Journal: JAMA Neurol Date: 2018-01-01 Impact factor: 18.302